What DEEPECHO does

DeepEcho is a Morocco-headquartered, Delaware-incorporated healthtech company founded in 2020 that builds AI-powered software for fetal ultrasound analysis. Its core platform applies deep learning and computer vision to ultrasound video loops to automatically identify standard fetal views, segment anatomical structures, and compute biometric measurements (BPD, head circumference, abdominal circumference, femur length) as well as amniotic fluid volume — claims validated in a Nature Communications publication on 172 patients. Additional modules include computer-assisted diagnosis for radiologists, teleguidance for remote expert support, and the Blind Sweep Platform, which is designed to allow minimally trained operators to acquire diagnostically usable ultrasound video.

The technology is delivered as enterprise software to healthcare providers (hospitals, clinics, radiologists, gynecologists, midwives) and government health ministries, with a specific Moroccan Ministry of Health pilot underway in the Béni Mellal-Khénifra region. Distribution runs through direct enterprise sales, embedding on Butterfly Network's handheld ultrasound platform via the Butterfly Garden AI marketplace, and integration with the Global Ultrasound Institute's training network across 124 countries. DeepEcho's revenue model is enterprise B2B licensing on an annual subscription cadence, with quote-based pricing not publicly disclosed. The company has received FDA 510(k) clearance (May 2025) and FDA Breakthrough Device Designation (March 2025), positioning it for US market entry alongside its existing African and European footprint.

Name

DEEPECHO

Legal name

DeepEcho Inc.

Website

https://deepecho.io

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

DeepEcho is a Morocco-based healthtech company that builds FDA-cleared AI software to automate fetal ultrasound biometry and amniotic fluid assessment, selling enterprise licenses to hospitals, government health ministries, and ultrasound platforms across Africa, Europe, and the US.

Ownership category

akta.pro rank

Product category

Prenatal Ultrasound AI Software

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ultrasound & Echography Systems (HLAHABAD)

akta.pro secondary industries

Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF), Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring) (HLALAFAG)

Keywords

• Fetal ultrasound AI
• Prenatal diagnostic software
• Medical imaging AI
• Obstetric decision support
• Deep learning healthcare

Headquarters

HQ city

Agdal

HQ country

Morocco

HQ region

Africa

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. AI-Powered Prenatal Ultrasound Software: DeepEcho generates revenue through licensing its FDA-cleared AI software platform for fetal ultrasound analysis to healthcare providers, hospitals, and healthcare systems. The platform is deployed across three continents targeting maternal health outcomes.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Core offering

DeepEcho develops and licenses an AI-powered software platform that analyzes fetal ultrasound video to automate biometric measurements (BPD, HC, AC, FL) and amniotic fluid volume assessment in real time. The platform is offered to hospitals, clinicians, and government health programs as an FDA-cleared decision-support tool with teleguidance capabilities, designed to reduce dependence on specialized sonographers and expand access to quality prenatal ultrasound in underserved settings.

Product overview

DeepEcho offers an AI-first healthtech platform focused on maternal and fetal diagnostics. The core product is the DeepEcho Fetal Ultrasound Analysis Platform, which combines automated fetal measurements, computer-assisted diagnosis, and teleguidance capabilities. The platform leverages deep learning trained on one of the world's largest fetal ultrasound datasets to automate biometric measurements and amniotic fluid assessment. The company also developed the Blind Sweep Platform (FDA Breakthrough Device Designation) for simplified ultrasound acquisition. Additional offerings include AI solutions specifically built for Butterfly Network's handheld ultrasound hardware, and teleguidance capabilities for remote diagnostic support. All modules share the same AI foundation for fetal ultrasound analysis while addressing different workflow needs: automated measurement, diagnostic assistance, remote guidance, and simplified acquisition.

Differentiator

Problem solved

Functional benefit

Brands

• DEEPECHO Blind Sweep Platform: FDA-designated prenatal ultrasound platform that automates fetal measurements and guides acquisition using AI-driven analysis of ultrasound videos.

Products and services

• DeepEcho Fetal Ultrasound Analysis Platform DeepEcho's flagship AI-powered software platform that analyzes fetal ultrasound video in real time to automate biometric measurements (BPD, HC, AC, FL) and amniotic fluid volume assessment, providing explainable decision support for radiologists, gynecologists, midwives, and minimally trained clinicians in hospitals and clinics.
• DEEPECHO Blind Sweep Platform FDA Breakthrough Device Designation-designated prenatal ultrasound platform that uses software-driven analysis of ultrasound videos to automate fetal measurements and guide acquisition, reducing dependence on specialized operators and expanding access to quality prenatal imaging.
• DeepEcho AI for Butterfly Network AI guidance solution for antenatal diagnosis built for integration with Butterfly Network's handheld point-of-care ultrasound platform, enabling fetal ultrasound AI on a portable single-probe system.
• DeepEcho Teleguidance and Remote Diagnosis Service Decision support service enabling remote experts to guide less experienced clinicians through fetal ultrasound procedures and provide diagnostic support from distant locations, extending specialist reach to resource-limited settings.

Quantifiable outcome

• >95% diagnostic accuracy in fetal measurements
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability3 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Kingdom of Morocco Ministry of HealthcoreStrategic or Co-development Partner · 6 May 2026Partnership agreement to integrate AI-powered prenatal ultrasound solutions into public healthcare facilities in Morocco. The initiative includes a pilot program in the Béni Mellal–Khénifra region, aiming to improve early detection of high-risk pregnancies in remote areas and support AI model development tailored to Morocco's demographics.
• Global Ultrasound Institute (GUSI)coreStrategic or Co-development Partner · 10 September 2025Strategic partnership to advance Point-of-Care Ultrasound (POCUS) education with focus on obstetric ultrasound. Combines DeepEcho's AI diagnostic tools with GUSI's training programs, which have trained over 18,000 learners across 124 countries with 500+ expert educators.
• Butterfly Network (Butterfly Garden)coreTechnology or Integration · 20 February 2024DeepEcho joined Butterfly Garden, Butterfly Network's AI marketplace, to deploy its fetal ultrasound AI on Butterfly's handheld imaging platform. The partnership leverages Butterfly's SDK to build AI guidance solutions for antenatal diagnosis compatible with Butterfly's single-probe, whole-body handheld ultrasound system.
• MicrosoftminorOthersCorporate supporter of DeepEcho as part of startup ecosystem support programs.
• NvidiaminorOthersCorporate supporter of DeepEcho providing technology infrastructure support.
• UM6P (Mohammed VI Polytechnic University)minorStrategic or Co-development PartnerUniversity partner providing early support through UM6P Ventures and research collaboration. DeepEcho acknowledges UM6P's support in developing innovation in Morocco and Africa.
• Cure (NYC Innovation Campus)minorStrategic or Co-development PartnerHealthcare innovation hub in New York City providing residency, seed money, mentorship, and ecosystem access to DeepEcho following Cure Xchange Challenge 2023 victory. Cure hosts over 20 startups and organizes 40+ industry events annually.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Caption Health (GE HealthCare): AI software that guides ultrasound image acquisition and automates measurements; directly comparable as a deep-learning ultrasound guidance platform. Acquired by GE HealthCare in 2023, validating the category and the M&A interest in DeepEcho's space.
• Sonio (Samsung Medison): AI-powered fetal ultrasound reporting and detection platform focused on prenatal diagnosis. Most direct fetal-AI comparable; acquired by Samsung Medison in 2024, demonstrating exit appetite from major ultrasound OEMs for this category.
• Intelligent Ultrasound: AI-based ultrasound image analysis and simulation tools, including fetal and cardiac applications. Directly comparable as a publicly listed AI-ultrasound specialist competing in DeepEcho's clinical use cases.
• DiA Imaging Analysis: AI-based image analysis for point-of-care ultrasound, automating measurements and clinical assessments across multiple anatomies. Directly comparable as an AI-ultrasound vendor with FDA-cleared offerings and a similar partnership/distribution go-to-market motion.

Broad incumbents

• Butterfly Network: Handheld whole-body ultrasound with the Butterfly Garden AI marketplace where DeepEcho is listed. Comparable as the platform provider for POCUS AI distribution, and a commercial partner, while also being a broader incumbent with AI ultrasound of its own.
• GE HealthCare: Largest global ultrasound equipment manufacturer with the deepest installed base and an expanding AI portfolio (including Caption Health). Competes indirectly by bundling AI into its own carts and handheld devices, putting pressure on independent AI-ultrasound specialists.
• Philips Ultrasound: Major global ultrasound manufacturer with native AI features across obstetrics, cardiology, and POCUS. Comparable as the incumbent DeepEcho must displace or partner with at the cart-and-system level of the market.

Emerging players

• Ultromics: AI-driven echocardiography analysis platform with FDA clearance. Comparable as an AI ultrasound imaging startup applying deep learning to automate specialist measurements, though focused on cardiac rather than fetal use.
• Koios Medical: AI clinical decision support for medical imaging (primarily breast and thyroid ultrasound). Comparable as an FDA-cleared AI imaging startup with a similar OEM-embedded and enterprise licensing motion.
• Babyscripts: Digital maternal health platform providing remote monitoring, education, and risk detection for pregnancies. Comparable as a maternal-health digital health vendor pursuing payer and health-system contracts, though focused on RPM/education rather than imaging AI.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DEEPECHO